Masaya Baba

7.3k total citations · 1 hit paper
117 papers, 5.5k citations indexed

About

Masaya Baba is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Masaya Baba has authored 117 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 47 papers in Pulmonary and Respiratory Medicine and 22 papers in Cancer Research. Recurrent topics in Masaya Baba's work include Renal cell carcinoma treatment (32 papers), Renal and related cancers (22 papers) and Cancer, Hypoxia, and Metabolism (16 papers). Masaya Baba is often cited by papers focused on Renal cell carcinoma treatment (32 papers), Renal and related cancers (22 papers) and Cancer, Hypoxia, and Metabolism (16 papers). Masaya Baba collaborates with scholars based in Japan, United States and Belgium. Masaya Baba's co-authors include Pang‐Hsien Tu, John Q. Trojanowski, Tatsuo Tomita, Kazuyasu Nakaya, Takeshi Iwatsubo, Shigeo Nakajo, W. Marston Linehan, Masahiro Yao, Seung‐Beom Hong and Laura S. Schmidt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Masaya Baba

107 papers receiving 5.4k citations

Hit Papers

Aggregation of alpha-synuclein in Lewy bodies of sporadic... 1998 2026 2007 2016 1998 400 800 1.2k

Peers

Masaya Baba
Carol J. Thiele United States
Heidi Scrable United States
Anne Vital France
Scott R. McKercher United States
Joseph M. Miano United States
Masaya Baba
Citations per year, relative to Masaya Baba Masaya Baba (= 1×) peers Guillem Genové

Countries citing papers authored by Masaya Baba

Since Specialization
Citations

This map shows the geographic impact of Masaya Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaya Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaya Baba more than expected).

Fields of papers citing papers by Masaya Baba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaya Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaya Baba. The network helps show where Masaya Baba may publish in the future.

Co-authorship network of co-authors of Masaya Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Masaya Baba. A scholar is included among the top collaborators of Masaya Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaya Baba. Masaya Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuroda, Seiji, Takanobu Motoshima, Yorifumi Satou, et al.. (2024). ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell Carcinoma. Current Issues in Molecular Biology. 46(12). 13675–13695.
2.
Baba, Masaya, et al.. (2023). MiT/TFE Family Renal Cell Carcinoma. Genes. 14(1). 151–151. 8 indexed citations
3.
Kadomatsu, Tsuyoshi, Chiaki Hara, Haruki Horiguchi, et al.. (2023). ANGPTL2 ‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion. Molecular Oncology. 17(12). 2637–2658. 5 indexed citations
4.
Wang, Cong, Naoya Masumori, Toshinari Yamasaki, et al.. (2023). T1a Renal Cell Carcinoma With Metastasis: Japanese Society of Renal Cancer Retrospective Multi-institute Results. Anticancer Research. 43(9). 4061–4065. 1 indexed citations
5.
ENDO, Mitsuhiro, Masaya Baba, Tamie Endoh, et al.. (2017). The FLCN-TFE3 axis regulates macrophage activation through cellular metabolism. Experimental Hematology. 53. S108–S109. 1 indexed citations
6.
Yan, Ming, Étienne Audet‐Walsh, Sanaz Manteghi, et al.. (2016). Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1α/ERRα. Genes & Development. 30(9). 1034–1046. 86 indexed citations
7.
Furuya, Mitsuko, Hisashi Hasumi, Masaya Baba, et al.. (2016). Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt–Hogg–Dubé syndrome. Laboratory Investigation. 97(3). 343–351. 2 indexed citations
8.
Baba, Masaya, et al.. (2012). SEROPREVALENCE OF IgG ANTI-T. GONDII ANTIBODY AMONG HIV-INFECTED PATIENTS IN MAIDUGURI, NORTH EASTERN NIGERIA. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Hong, Seung‐Beom, HyoungBin Oh, Vladimir Valera, et al.. (2010). Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization. PLoS ONE. 5(12). e15793–e15793. 127 indexed citations
10.
Yao, Masahiro, Ying Huang, Kéiko Hattori, et al.. (2008). A three‐gene expression signature model to predict clinical outcome of clear cell renal carcinoma. International Journal of Cancer. 123(5). 1126–1132. 39 indexed citations
11.
Hattori, Kéiko, Jun‐ichi Teranishi, Catherine A. Stolle, et al.. (2006). Detection of germline deletions using real‐time quantitative polymerase chain reaction in Japanese patients with von Hippel–Lindau disease. Cancer Science. 97(5). 400–405. 20 indexed citations
12.
Natsugoe, Shoji, Masato Ikeda, Masaya Baba, et al.. (2003). Long-term survivors of advanced esophageal cancer without surgical treatment: a multicenter questionnaire survey in Kyushu, Japan. Diseases of the Esophagus. 16(3). 239–242. 7 indexed citations
13.
Kondo, Keiichi, Masahiro Yao, Kazuki Kobayashi, et al.. (2001). PTENMMAC1TEP1 mutations in human primary renal‐cell carcinomas and renal carcinoma cell lines. International Journal of Cancer. 91(2). 219–224. 70 indexed citations
14.
Kato, Yukio, Jean-Marc Lewalle, Yuh Baba, et al.. (2001). Induction of SPARC by VEGF in Human Vascular Endothelial Cells. Biochemical and Biophysical Research Communications. 287(2). 422–426. 52 indexed citations
15.
Yoshida, Minoru, Shingo Ashida, Keiichi Kondo, et al.. (2000). Germ‐line Mutation Analysis in Patients with von Hippel‐Lindau Disease in Japan: An Extended Study of 77 Families. Japanese Journal of Cancer Research. 91(2). 204–212. 47 indexed citations
16.
Yoshida, Michihiko, Akio Yamashita, Masaya Baba, et al.. (2000). MAPK Upstream Kinase (MUK)-binding Inhibitory Protein, a Negative Regulator of MUK/Dual Leucine Zipper-bearing Kinase/Leucine Zipper Protein Kinase. Journal of Biological Chemistry. 275(28). 21247–21254. 38 indexed citations
17.
Okuda, Heiwa, Syu-ichi Hirai, Yasuyuki Takaki, et al.. (1999). Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC Isotypes. Biochemical and Biophysical Research Communications. 263(2). 491–497. 72 indexed citations
18.
Iíkura, Yoji, Charles K. Naspitz, Haruki Mikawa, et al.. (1992). Prevention of asthma by ketotifen in infants with atopic dermatitis.. PubMed. 68(3). 233–6. 102 indexed citations
19.
Herdewijn, Piet, Jan Balzarini, Masaya Baba, et al.. (1988). Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. Journal of Medicinal Chemistry. 31(10). 2040–2048. 108 indexed citations
20.
Baba, Masaya, et al.. (1978). [Cystic craniopharyngioma extending down into the upper cervical spinal canal (author's transl)].. PubMed. 6(7). 687–93. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026